Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer.
Article
in English
| IMSEAR
| ID: sea-138729
ABSTRACT
Management of locally advanced non-small cell lung cancer is associated with a poor overall survival using concurrent chemoradiotherapy. Therefore, newer approaches to treatment which enable dose escalation are warranted. Interstitial brachytherapy in lung is a new emerging concept with many distinct advantages. We report here a case of locally advanced non-small cell lung cancer with residual disease after conventional treatment. The patient was successfully treated using percutaneous interstitial brachytherapy and is disease-free at 18-month follow-up.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Radiotherapy Dosage
/
Brachytherapy
/
Humans
/
Male
/
Antineoplastic Combined Chemotherapy Protocols
/
Chemotherapy, Adjuvant
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Middle Aged
Language:
English
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS